Abstract 580P
Background
Primary tumor location (PTL) is a well-established prognostic factor in stage III and IV colorectal cancer (CRC), with right-sided CRC (RSCC) showing a worse prognosis compared to left-sided CRC (LSCC). However, the impact of PTL on stage II CRC remains uncertain. One explanation for these inconsistencies is the potential confounding effect of molecular biomarkers, such as MMR status. Therefore, there is a need to elucidate the prognostic value of PTL, as well as the role of biomarkers in this effect.
Methods
This study utilized observational data from a retrospective cohort obtained from the Belgian Cancer Registry (BCR). The study population comprised all patients diagnosed with pathologically confirmed stage II CRC in Belgium from January 1st, 2015, to December 31st, 2016 (n= 3,278). Information on PTL, demographics, pathologic T category (pT category), and molecular biomarkers (including MMR status, BRAF and KRAS mutations) was collected from the registry, along with vital status to calculate overall survival (OS). The primary aim of this study was to investigate the independent prognostic value of PTL in stage II CRC. Additionally, we assessed whether potential confounding factors, such as biomarkers and demographics, influenced the prognostic effect of PTL.
Results
In the univariate analysis, patients with stage II RSCC had a significantly worse OS compared to those with LSCC (including rectal cancer; p-value=0.0055 and excluding rectal cancer; p-value=0.0035). Higher age and pT4 were also significantly associated with worse OS. However, in the multivariable analysis, only gender, age, and pathologic T-stage were found to be significant predictors of OS. PTL was not a significant factor in multivariable analysis. Furthermore, biomarkers such as MMR-status, BRAF-, and KRAS mutations did not show a significant effect on OS in either analysis.
Conclusions
Our analysis led us to the conclusion that PTL is not an independent prognostic factor in stage II. Notably, we observed confounding effects between patient characteristics and the prognostic impact of PTL, such as older age at diagnosis and shorter OS in patients with RSCC. Furthermore, molecular biomarkers did not have a statistically significant effect on OS in stage II CRC.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University of Antwerp.
Funding
Antwerp University Hospital.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
538P - Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials
Presenter: Giulia Pretelli
Session: Poster session 10
539P - Epidemiology and prognostic factors of lung cancer and brain metastases: A 10-year retrospective population cohort study in Girona, Spain
Presenter: Eduard Teixidor Vilà
Session: Poster session 10
540P - Impact of adjuvant radiotherapy (ART) on survival time in patients with hemangiopericytoma (HPC): A population study
Presenter: Tala Alshwayyat
Session: Poster session 10
541P - A multicenter study evaluating the clinical and molecular characteristics of adult patients with diffuse midline and non-midline K27M altered gliomas
Presenter: Manuel Mazariegos Rubi
Session: Poster session 10
542P - Drug screening in Li-Fraumeni syndrome brain tumor models
Presenter: Anna Kolodziejczak
Session: Poster session 10
543P - Bevacizumab and hydroxyurea treatment in grade 2 and 3 meningioma: A monocentric experience
Presenter: Giulia Cerretti
Session: Poster session 10
544P - Clinical and molecular features of primary central nervous system tumor with Lynch syndrome
Presenter: Nan Liu
Session: Poster session 10
545P - Antibody-fragment based immunotherapeutic approaches for medulloblastoma and rhabdomyosarcoma
Presenter: Judith Niesen
Session: Poster session 10
546P - Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
Presenter: Alexandre Bertucci
Session: Poster session 10
547P - Clinicopathological and molecular study of embryonal tumours with multilayered rosettes
Presenter: Lianghong Teng
Session: Poster session 10